HAL
41
2
OKE
71
6
AES
37
-10
FLS
49
-8
CMS
48
-12
HES
62
-4
CI
49
4
EQR
60
-8
NI
62
-6
CAT
62
-4
TXN
50
7
GOOG
83
-4
ADBE
72
2
AME
50
2
RL
59
-14
MRK
38
-3
IFF
63
9
TGNA
54
-10
MA
55
-3
ABBV
60
-8
HAL
41
2
OKE
71
6
AES
37
-10
FLS
49
-8
CMS
48
-12
HES
62
-4
CI
49
4
EQR
60
-8
NI
62
-6
CAT
62
-4
TXN
50
7
GOOG
83
-4
ADBE
72
2
AME
50
2
RL
59
-14
MRK
38
-3
IFF
63
9
TGNA
54
-10
MA
55
-3
ABBV
60
-8
Financhill
Back

Alnylam Pharmaceuticals Vs. BridgeBio Pharma Industry Stock Comparison

Buy
61

ALNY
Alnylam Pharmaceuticals

Last Price:
243.28
Seasonality Move:
15.98%
Sell
37

BBIO
BridgeBio Pharma

Last Price:
25.17
Seasonality Move:
12.97%
Buy
61
Alnylam Pharmaceuticals (ALNY) is a Buy

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $243.32. The Score for ALNY is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
  • ALNY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
37
BridgeBio Pharma (BBIO) is a Sell

Is BridgeBio Pharma a Buy, Sell or Hold?

  • The current BridgeBio Pharma [BBIO] share price is $25.20. The Score for BBIO is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • BBIO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $243.32
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing slight buying pressure.

BBIO Stock Price Chart

What is BridgeBio Pharma's stock price today?

  • The BridgeBio Pharma share price today is $25.20
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BBIO is experiencing selling pressure, which indicates risk of future bearish movement.

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 24.3 Buy
Relative Strength Index (14 RSI): 86.74 Buy
Chaikin Money Flow: 174062 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (137.09 - 211.95) Buy
Bollinger Bands (100): (135.42 - 179.08) Buy

BBIO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.9 Sell
Relative Strength Index (14 RSI): 42.92 Sell
Chaikin Money Flow: -980817 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (25.29 - 28.65) Sell
Bollinger Bands (100): (25.73 - 32.23) Sell

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 220.62 Buy
20-day SMA: 180.99 Buy
50-day SMA: 161.59 Buy
200-day SMA: 166.12 Buy
8-day EMA: 223.64 Buy
20-day EMA: 193.95 Buy
50-day EMA: 171.81 Buy
200-day EMA: 168.84 Buy

BBIO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 25.02 Buy
20-day SMA: 26.71 Sell
50-day SMA: 27.27 Sell
200-day SMA: 30.23 Sell
8-day EMA: 25.31 Sell
20-day EMA: 26.31 Sell
50-day EMA: 27.4 Sell
200-day EMA: 28.22 Sell

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.32 per share, a decrease next quarter of $0.12 per share, a decrease this year of $0.46 per share, and an increase next year of $1.83 per share.

BridgeBio Pharma Earnings Growth & BBIO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, an increase next quarter of $0.30 per share, an increase this year of $2.47 per share, and a decrease next year of $2.17 per share.

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

BridgeBio Pharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):